KCNJ1
Potassium Inwardly Rectifying Channel Subfamily J Member 1
Gene Information Card
| Symbol | KCNJ1 |
|---|---|
| Full Name | Potassium Inwardly Rectifying Channel Subfamily J Member 1 |
| Gene Type | Protein coding |
| Chromosomal Location | 11q24.3 |
| NCBI Gene ID | 3758 ncbi.nlm.nih.gov/gene/3758 |
| Ensembl ID | ENSG00000151704 |
| UniProt ID | P48048 |
| OMIM ID | 600359 |
| HGNC ID | 6255 |
| Aliases | ROMK, KIR1.1, KCNJ1a, KCNJ1b |
Description
KCNJ1 encodes the ROMK (Kir1.1) potassium channel, a member of the inward rectifier potassium channel family. It is primarily expressed in the kidney, where it mediates potassium recycling in the thick ascending limb of Henle's loop and potassium secretion in the collecting duct. ROMK is essential for maintaining electrolyte homeostasis and urine concentration. Mutations in KCNJ1 cause Bartter syndrome type 2, a renal tubular disorder characterized by salt wasting, hypokalemia, and metabolic alkalosis.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Bartter syndrome type 2 | Loss-of-function mutations in KCNJ1 impair potassium recycling in the thick ascending limb, leading to salt wasting and hypokalemia. | ClinVar, OMIM |
| Hyperprostaglandin E syndrome | Severe form of Bartter syndrome with additional features such as nephrocalcinosis and polyhydramnios. | OMIM |
| Neonatal Bartter syndrome | Early-onset renal tubular disorder due to KCNJ1 mutations, presenting with polyuria and failure to thrive. | ClinVar |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Kidney | 12.5 | High |
| Adrenal gland | 1.2 | Low |
| Testis | 0.8 | Low |
| Brain | 0.5 | Not detected |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HEK 293 | 0.3 | Low expression |
| HK-2 (kidney proximal tubule) | 8.1 | Moderate expression |
| MDCK (Madin-Darby canine kidney) | 6.7 | Moderate expression |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.532C>T (p.Arg178Trp) | Missense | Rare | Loss of function; associated with Bartter syndrome type 2 |
| c.1010G>A (p.Arg337His) | Missense | Rare | Loss of function; impairs channel conductance |
| c.1A>G (p.Met1Val) | Start loss | Very rare | Complete loss of protein expression |
Mutation functional classification
Loss of Function (LOF)
Most KCNJ1 mutations are loss-of-function, reducing or abolishing potassium channel activity, leading to Bartter syndrome type 2.
Gain of Function (GOF)
No gain-of-function mutations have been reported for KCNJ1.
Dominant Negative (DN)
Some missense mutations may exert dominant-negative effects when co-expressed with wild-type subunits, though autosomal recessive inheritance is typical.
View complete mutation data:
Gene Ontology (GO)
| • Inward rectifier potassium channel activity (GO:0005242) | • Potassium ion transport (GO:0006813) |
| • Potassium ion import across plasma membrane (GO:0010107) | • Potassium ion transmembrane transport (GO:0071805) |
| • Plasma membrane (GO:0005886) |
Pathways
• Renal cell potassium transport
• Bartter syndrome pathway
• Inward rectifier potassium channels
Protein Summary
The ROMK protein (UniProt P48048) is a 391-amino acid integral membrane protein with two transmembrane domains and a pore-forming loop. It forms homotetrameric channels that conduct potassium ions into cells in an inwardly rectifying manner. ROMK is regulated by intracellular pH, ATP, and phosphorylation. In the kidney, it localizes to the apical membrane of thick ascending limb and collecting duct cells, where it facilitates potassium recycling and secretion.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| KCNJ12 Knockout HEK293 Cell Line | EDJ-KQ1932 | Human | 3768 | Details Get a Quote |
| KCNJ11 Knockout HEK293 Cell Line | EDJ-KQ3740 | Human | 3767 | Details Get a Quote |
| KCNJ15 Knockout HEK293 Cell Line | EDJ-KQ4253 | Human | 3772 | Details Get a Quote |
| KCNJ1 Knockout HEK293 Cell Line | EDJ-KQ5031 | Human | 3758 | Details Get a Quote |
| KCNJ14 Knockout HEK293 Cell Line | EDJ-KQ5042 | Human | 3770 | Details Get a Quote |
| KCNJ16 Knockout HEK293 Cell Line | EDJ-KQ5043 | Human | 3773 | Details Get a Quote |
| KCNJ13 Knockout HEK293 Cell Line | EDJ-KQ5044 | Human | 3769 | Details Get a Quote |
| KCNJ10 Knockout HEK293 Cell Line | EDJ-KQ5045 | Human | 3766 | Details Get a Quote |
| KCNJ18 Knockout HEK293 Cell Line | EDJ-KQ13893 | Human | 100134444 | Details Get a Quote |
| KCNJ14 Knockout A-549 Cell Line | EDJ-KQ27945 | Human | 3770 | Details Get a Quote |
| KCNJ14 Knockout HCT 116 Cell Line | EDJ-KQ27946 | Human | 3770 | Details Get a Quote |
| KCNJ14 Knockout HeLa Cell Line | EDJ-KQ27947 | Human | 3770 | Details Get a Quote |
| KCNJ16 Knockout A-549 Cell Line | EDJ-KQ27949 | Human | 3773 | Details Get a Quote |
| KCNJ12 Knockout HCT 116 Cell Line | EDJ-KQ21861 | Human | 3768 | Details Get a Quote |
| KCNJ12 Knockout HeLa Cell Line | EDJ-KQ21862 | Human | 3768 | Details Get a Quote |
Displaying Records 1 To 15 Of 38 Records
- 1
- 2
- Next Page »